OrphanDrug
OrphanDrug
Pharma Knowledge Base

Cyprus facial-neuromusculoskeletal syndrome

MeSH: C536229ORPHA: 2674

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

Cyprus facial-neuromusculoskeletal syndrome is an exceedingly rare, genetic malformation syndrome characterized by a striking facial appearance, variable skeletal deformities, and neurological defects

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

MeSH Code

C536229

Orphanet Code

ORPHA:2674
Cyprus facial-neuromusculoskeletal syndrome
MeSHC536229
OrphanetORPHA:2674
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
Cyprus facial-neuromusculoskeletal syndrome | OrphanDrug